Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Union Budget
Budget 2011-2012 Home
Industry Expectations - Budget 2011-2012
Industry Reactions - Budget 2011-2012
Budget 2010-2011
Budget 2010-2011 Home
Industry Expectations - Budget 2010-2011
Industry Reactions - Budget 2010-2011
Contributor's Corner
Bonanza Portfolio
Hemant K Gupta
Krish Bhatt
S A A R T H I
Trinity Investments
Exchange Information
BSE 2009 Holidays
NSE 2009 Holidays
Investor Guide
Depository & Dematerialisation
Grievance Redressal
Investor Guide
SEBI
Trading of Securities
Transfer of Securities
Your Rights
Budget 2009-2010
Budget 2009-2010 Home
Industry Expectations - Budget 2009-2010
Industry Reactions - Budget 2009-2010
Interim Budget 2009-2010 Home
Industry Expectations - Interim Budget 2009
Budget 2008-2009
Railway Budget 2008-2009
Industry Expectations - Budget 2008
Union Budget 2008-2009
Highlights of Budget 2008-2009
Summary of Budget 2008-2009
Industry Reactions - Budget 2008
IPOs
Current IPOs
Past IPOs
IPO Subscription
Mutual Funds
Gold Exchange Traded Fund
MF Unique Holding
Forthcoming Dividends
ELSS Schemes Comparison
Tax Plans
New Fund Offers
Research
Arbitrages
Equity
Market Whispers
Tax Planning
Home
Equity Linked Savings Scheme
Post Office MIS
9% GOI Senior Citizens Savings Scheme
8% Savings (Taxable) Bonds
Kisan Vikas Patra
National Savings Certificate
Public Provident Fund
Stock Report

| More

Lupin Receives Tentative FDA Approvals for Generic Nuvigil Tablets and Generic Oracea Capsules

Posted On: 2013-08-13 03:17:43

MSD, one of the world's leading players in 23-valent Pneumococcal Polysaccharide Vaccines category and Lupin Limited have formed an India-specific strategic partnership. Within the scope of partnership, Lupin will have a non-exclusive license to market, promote and distribute 23-valent Pneumococcal Polysaccharide Vaccine under a different brand name in India.

Pneumococcal disease is an infection caused by bacteria named Streptococcus pneumoniae and it results in variety of invasive and non-invasive pneumococcal diseases with pneumonia being the most common presentation in adults. Pneumococcal disease kills more patients worldwide than any other vaccine preventable diseases. Worldwide 1.6 million people die of pneumococcal disease every year which translates to 3 people dying every minute. Adults with co morbid conditions like chronic lung disease (COPD etc.), diabetes, chronic heart diseases, chronic liver diseases, immune compromised diseases as well as adults more than 65 years of age are at increased risk for pneumococcal diseases than healthy adults.

A recent study from India showed that the case fatality rate due to invasive pneumococcal disease observed in elderly is 26.4% which is much higher than that in children and highlights the need for preventive interventions in adults1

Identifying this significant risk, this partnership is built on a patient centric model, which will help improve vaccination rate for pneumococcal disease, in particular to high risk population group to help reduce incidence and mortality in adults.

Pneumococcal polysaccharide vaccine (PPV)

- Pneumococcal polysaccharide vaccine (PPV) addresses the need of prevention of pneumococcal disease in India with its proven efficacy and broader coverage.

- PPV23 provides broader coverage and has proven efficacy for prevention of pneumococcal diseases which help addresses the need of prevention of pneumococcal disease in India

- Based on the clinical experience since last 3 decades, PPV23 has good safety profile

- Recent India focused study showed that more than 80% of invasive serotype groups of Streptococcus pneumoniae causing disease in the elderly in India are included in the formulation of PPV 23 which makes this vaccine relevant from India perspective

- PPV23 is recommended worldwide for prevention of pneumococcal diseases in adults by leading medical societies like Advisory committee on Immunization Practices, American Diabetes Association, American Thoracic society, Geriatric society of India etc.

Shares of Lupin Ltd was last trading in BSE at Rs.839.60, up by Rs.20.40 or 2.49%. The stock hit an intraday high of Rs.847.55 and low of Rs.817.60.

The total traded quantity was 0.73 lakhs compared to 2 week average of 1.45 lakhs.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Kwality Ltd reports financial results for the Fourth Quarter and Year ended 31 March, 2017
CRISIL assigns credit ratings to Balrampur Chini Mills Ltd
Prithvi Exchange India Ltd Board recommends Dividend of 5% for 2016-17
Nagarjuna Agrichem Ltd announces FY17 results
Hindustan Tin Works Ltd Board recommends Dividend of Rs. 1 for 2016-17
Lotus Eye Care Hospital Ltd Board recommends Final Dividend of Rs. 0.50 for 2016-17
Gulshan Polyols Ltd Board recommends Final Dividend of Rs. 0.30 for 2016-17
Siyaram Silk Mills Ltd Board recommends Dividend of Rs. 15 for 2016-17
Zenith Fibres Ltd Board recommends Dividend of 20% for 2016-17
Nagarjuna Agrichem Ltd Board recommends Final Dividend of Rs. 0.125 for 2016-17
Time Technoplast Ltd Board recommends Dividend of Rs. 0.65 for 2016-17
Reliance Chemotex Industries Ltd Board recommends Dividend of Rs. 1 for 2016-17
Transpek Industry Ltd Board recommends Dividend of Rs. 9 for 2016-17
Kiran Vyapar Ltd Board recommends Dividend of Rs. 2.50 for 2016-17
PTC India Ltd Board recommends Dividend of Rs. 3 for 2016-17
Shree Ajit Pulp And Paper Ltd Board recommends Final Dividend of Rs. 0.75 for 2016-17
Porwal Auto Components Ltd Board recommends Dividend of Rs. 0.50 for 2016-17
Nitin Castings Ltd Board recommends Dividend of Rs. 1 for 2016-17
B&A Ltd Board approves Dividend of Rs. 3 for 2016-17
Insecticides India Ltd Board recommends Dividend of Rs. 2 for 2016-17
Rapicut Carbides Ltd Board approves Dividend of Rs. 1.50 for 2016-17
NCL Industries Ltd Board recommends Final Dividend of Rs. 1.50 for 2016-17
Shivalik Rasayan Ltd recommends final dividend of Rs. 1 for 2016-17
Multiplus Holdings Ltd Board recommends Dividend of Rs. 0.20 for 2016-17
Indraprastha Gas Ltd Board recommends Final Dividend of Rs. 5 for 2016-17
Ceejay Finance Ltd Board approves Dividend of Rs. 1.50 for 2016-17
Virat Crane Industries Ltd recommends final dividend of Rs. 0.50 for 2016-17
Balrampur Chini Mills Ltd to treat interim dividend as final dividend
Poddar Pigments Ltd Board approves Dividend of Rs. 1 for 2016-17
National Fittings Limited Board recommends Final Dividend of Rs. 2 for 2016-17
Sarla Performance Fibers Ltd Board recommends Dividend & Not considered Buyback of Shares
Igarashi Motors India Ltd Board approves Bonus Shares
Gini Silk Mills Ltd Board recommends Dividend of 5% for 2016-17
Premier Explosives Ltd Board recommends Dividend of Rs. 3 for 2016-17
Valson Industries Ltd Board approves Dividend of Rs. 1 for 2016-17
Divyashakti Granites Ltd Board recommends Final Dividend of Rs. 1.50 for 2016-17
Rubfila International Ltd Board recommends Dividned of Rs. 0.75 for 2016-17
Arihant Capital Markets Ltd Board recommends Dividend of Rs. 0.75 for 2016-17
Balkrishna Paper Mills Ltd to raise Rs. 25 crores
Bhandari Hosiery Exports Ltd Board recommends Dividend of Rs. 0.01 for 2016-17
Vidli Restaurants Ltd Board approves Dividend of Rs. 0.50 for 2016-17
Sunil Agro Foods Ltd Board recommends Dividend of Rs. 0.50 for 2016-17
India Cements Ltd Board recommends Dividend of Rs. 1 for 2016-17
India Gelatine & Chemicals Ltd Board recommends Dividend of Rs. 0.90 for 2016-17
Cil Securities Ltd Board recommends Dividend of Rs. 0.50 for 2016-17
Super Crop Safe announces FY17 results
Kellton Tech wins 'Best e-Governance Initiative of the Year' at Digital India Summit
Tata Chemicals Ltd Fixes Book Closure for Dividend & 78th AGM
Indian Terrain Fashions Ltd appoints new CFO
South India Paper Mills Ltd Fixes Book Closure for Dividend & 58th AGM


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2017